These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9685274)

  • 1. Number needed to screen: development of a statistic for disease screening.
    Rembold CM
    BMJ; 1998 Aug; 317(7154):307-12. PubMed ID: 9685274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the point: will screening mammography save my life?
    Keen JD; Keen JE
    BMC Med Inform Decis Mak; 2009 Apr; 9():18. PubMed ID: 19341448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
    Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
    Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number needed to screen: lives saved over 20 years of follow-up in mammographic screening.
    Tabar L; Vitak B; Yen MF; Chen HH; Smith RA; Duffy SW
    J Med Screen; 2004; 11(3):126-9. PubMed ID: 15333270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.
    Lee SJ; Boscardin WJ; Stijacic-Cenzer I; Conell-Price J; O'Brien S; Walter LC
    BMJ; 2013 Jan; 346():e8441. PubMed ID: 23299842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ['Number needed to screen': a tool for assessment of prevention programs].
    Boomsma LJ; van Lidth de Jeude CP
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2345-8. PubMed ID: 11129969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.